Partnership for Parks: Beautifying NYC Parks, One Flower Bed at a Time
We would like to extend a much-deserved thank you to the volunteers who came out to Dewitt Clinton Park to plant in, and mulch, the flower beds.
CFGI Honored at BBJ’s First Ever Middle Market Leaders Event
We are humbled to announce that CFGI was among the 50 honorees recognized at the Boston Business Journal’s inaugural Middle Market Leaders event February 12.
Should You Insource, Outsource or Co-Source Your SOX Compliance Program?
The pros and cons of different SOX compliance program models Every publicly traded company is legally obligated to comply with the Sarbanes-Oxley (SOX) Act, and that compliance inevitably comes at a cost.
With Support from CFGI, Applied Therapeutics Closes Public Offering of Common Stock
CFGI’s Capital Markets team supported Applied Therapeutics (Nasdaq: APLT) with its follow-on public offering of 3,152,712 shares of its common stock, including the exercise in full of the underwriters’ option to purchase 411,223 additional shares of common stock.
1Life Healthcare (One Medical) Closes $245 million Initial Public Offering of Common Stock
CFGI’s Capital Markets team supported 1Life Healthcare Inc.
Insight and Advice From 3 Seasoned SOX Specialists
CFGI recently rounded up a few of its top Sarbanes-Oxley specialists to discuss all things SOX compliance on camera.
Happy 2020 Lunar New Year
The Lunar New Year celebration is just around the corner, Jan 25, 2020! The Lunar New Year is a huge celebration in Asia amongst the Chinese, Vietnamese and Korean.
CFO’s Guide to Significant Deficiencies and Material Weaknesses
The PCAOB defines a material weakness as, “a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the company’s annual or interim financial statements will not be prevented or detected on a timely basis.